Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review

Hodgkin lymphoma (HL) is a potentially curable lymphoma, and modern therapy is expected to successfully cure more than 80% of the patients. Second-line salvage high-dose chemotherapy and autologous stem cell transplantation (auto-SCT) have an established role in the management of refractory and rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Fedele, Roberta, Martino, Massimo, Recchia, Anna Grazia, Irrera, Giuseppe, Gentile, Massimo, Morabito, Fortunato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695673/
https://www.ncbi.nlm.nih.gov/pubmed/26788526
http://dx.doi.org/10.1155/2015/968212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695673/
https://www.ncbi.nlm.nih.gov/pubmed/26788526
http://dx.doi.org/10.1155/2015/968212

Ejemplares similares